Figure 1.
Overview of the number of pharmacokinetic/pharmacodynamic (PK/PD) trials undertaken for obtaining approval as a biosimilar. A trial is counted as a PK/PD trial if the primary endpoint is PK or PD
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.